Post Market Clinical Study to Evaluate the Performance of the Versius Surgical System

计划入组 100 人 · 首次发布于 2025 年 7 月 31 日

Robotic Curriculum for Young Surgeons

计划入组 500 人 · 首次发布于 2023 年 7 月 25 日

Novel Robotic Surgical System for Minimally Invasive Surgery

计划入组 20 人 · 首次发布于 2021 年 12 月 9 日

RBM-009（Ribomic Inc）

PEGylated anti-fibroblast growth factor 2 aptamer (Ribomic)

Ribocil

RIBOMIC INC.

Japan

RIBOMIC USA INC.

United States

Piomic Medical AG

Switzerland

Umedaptanib Pegol Shows Promise in Phase IIa Trial for Achondroplasia

RIBOMIC's Umedaptanib Pegol Shows Promise in Phase IIa Achondroplasia Trial

RIBOMIC's Umedaptanib Pegol Shows Promising Growth Rate Improvements in Phase 2 Achondroplasia Trial